Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Horii

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
BMC Research Notes|April 2, 2020
Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in JapanTakeshi Horii, Koichiro Atsuda
Oncology|August 14, 2023
Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims DatabaseHiroaki Ohta, Takeshi Horii, Takeo Yasu
BMJ Open Diabetes Research & Care|April 21, 2023
Risk of non-hypoglycemic agents for hypoglycemia-related hospitalization in patients with type 2 diabetes: a large-scale medical receipt database analysisTakeshi Horii, Mai Otsuka, Takeo Yasu
Scientific Reports|September 12, 2019
Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysisTakeshi Horii, Makiko Iwasawa, Yusuke Kabeya, et al.
Journal of Diabetes Investigation|July 30, 2023
Real-world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium-glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score-matched model analysis in JapanTakeshi Horii, Yoichi Oikawa, Akira Shimada, et al.
Cureus|April 14, 2025
Semaglutide Adherence and Cardiovascular Diseases in Patients With Type 2 Diabetes: Evidence From Real-World Data in JapanChikako Masudo, Takeshi Horii, Ririka Suzuki, et al.
Journal of Diabetes Investigation|January 15, 2021
On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetesTakeshi Horii, Yoichi Oikawa, Koichiro Atsuda, et al.
BMC Geriatrics|January 15, 2025
Association between edaravone use and activities of daily living in older patients with atherothrombotic stroke: an observational study using Japanese real-world dataYukari Ogawa, Hiroko Akiyama, Takeshi Horii, et al.
Journal of Diabetes Investigation|May 31, 2019
Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-naïve patients with type 2 diabetes in JapanTakeshi Horii, Makiko Iwasawa, Jyunichi Shimizu, et al.
Journal of Diabetes Investigation|July 13, 2021
Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort studyTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
BMC Research Notes|April 2, 2020
Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in JapanTakeshi Horii, Koichiro Atsuda
Oncology|August 14, 2023
Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims DatabaseHiroaki Ohta, Takeshi Horii, Takeo Yasu
BMJ Open Diabetes Research & Care|April 21, 2023
Risk of non-hypoglycemic agents for hypoglycemia-related hospitalization in patients with type 2 diabetes: a large-scale medical receipt database analysisTakeshi Horii, Mai Otsuka, Takeo Yasu
Scientific Reports|September 12, 2019
Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysisTakeshi Horii, Makiko Iwasawa, Yusuke Kabeya, et al.
Journal of Diabetes Investigation|July 30, 2023
Real-world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium-glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score-matched model analysis in JapanTakeshi Horii, Yoichi Oikawa, Akira Shimada, et al.
Cureus|April 14, 2025
Semaglutide Adherence and Cardiovascular Diseases in Patients With Type 2 Diabetes: Evidence From Real-World Data in JapanChikako Masudo, Takeshi Horii, Ririka Suzuki, et al.
Journal of Diabetes Investigation|January 15, 2021
On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetesTakeshi Horii, Yoichi Oikawa, Koichiro Atsuda, et al.
BMC Geriatrics|January 15, 2025
Association between edaravone use and activities of daily living in older patients with atherothrombotic stroke: an observational study using Japanese real-world dataYukari Ogawa, Hiroko Akiyama, Takeshi Horii, et al.
Journal of Diabetes Investigation|May 31, 2019
Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-naïve patients with type 2 diabetes in JapanTakeshi Horii, Makiko Iwasawa, Jyunichi Shimizu, et al.
Journal of Diabetes Investigation|July 13, 2021
Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort studyTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, et al.
Pageof 4